Podcasts about Lancet

This episode is brought to you by Rupa Health, Cozy Earth, and InsideTracker.Many people think of metabolism as one specific system in the body, when in fact it's the sum of many different processes that are serving other vital roles for us as well. Our bodies are not closed systems, so our environment, social networks, diet, hormones, microbiome, genetics, and more, all influence how well our metabolism works, or how well we can extract energy from our food. I'm so happy to sit down with my good friend Dr. William Li to talk about what metabolism really means, why the old way of thinking about metabolism hasn't helped us, and how to make positive impacts on our metabolism at any age. Dr. William Li is a world-renowned physician, scientist, speaker, and author of Eat to Beat Disease - The New Science of How Your Body Can Heal Itself. He is best known for leading the Angiogenesis Foundation. His groundbreaking work has impacted more than 70 diseases, including cancer, diabetes, blindness, heart disease, and obesity. An author of over 100 scientific publications in leading journals such as Science, the New England Journal of Medicine, The Lancet, and more, Dr. Li has served on the faculties of Harvard, Tufts, and Dartmouth Medical School.This episode is brought to you by Rupa Health, Cozy Earth, and InsideTracker.You can check out a free, live demo with a Q&A or create an account at RupaHealth.com.Right now, get 40% off your Cozy Earth sheets at cozyearth.com and use code MARK40.InsideTracker is offering my community 20% off at insidetracker.com/drhyman.Here are more details from our interview (audio version / Apple Subscriber version):Shifting away from the idea that eating less and exercising more is the key to weight loss (4:51 / 2:12) How calories affect metabolism (13:14 / 11:25) Research measuring the four phases of metabolism as we age (16:07 / 13:36) What is metabolism? (24:03 / 21:26) Common myths about metabolism (28:35 / 24:37) Supporting the gut microbiome to raise metabolism and promote health (36:18 / 32:03) Foods that mimic caloric restriction (40:27 / 36:10) Our body's ability to reverse disease (52:59 / 46:21) Reducing stress in a doomscrolling society (54:07 / 49:30) How to restore health to your metabolism (56:03/ 51:56) Mentioned in this episodePerspective: Obesity—an unexplained epidemicCompeting paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin modelsDaily energy expenditure through the human life courseGet a copy of Dr. Li's book, Eat to Beat Disease: The New Science of How Your Body Can Heal Itself, here and check out his Masterclass with Dr. William Li here. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

This week, we continue our series on Aging, as Dr. Prather explains how Collagen is one of the fountains of youth and is something that everyone needs more of. In this episode, we talk about:—The shocking conclusions from the prestigious medical journal The Lancet's scientific commission investigating the origins of COVID-19. —What the Vaccine Adverse Events Reporting System (VAERS) has shown so far about the COVID vaccine. And how the U.S. Government has spent zero money compensating those with vaccine injuries.—The data from U.S. life insurance companies showing an unprecedented increase in deaths among adults under the age of 40 and a shocking increase in those diagnosed with Cancer.—How Collagen is involved in every single organ and system of our body.—The reason why Dr. Prather says Collagen is almost always involved in diseases of aging. And how you would look like you were 25 for the rest of your life if your Collagen was up to par.—How Collagen begins to drop off at the age of 25 and is the substance most connected to how youthful and beautiful a person looks. —Why Collagen supplementation works best when taken in a chewable form.—The reason why a vegan form of Collagen is the best for the body to process. And the findings that Collagen derived from animals has been found to be high in heavy metal toxicity.—How "everybody" needs more Collagen, but especially Women after Menopause.—Plus, the story of how Holistic Integration's own Natrum Naturals Vegan Collagen Boost Gummy was developed and the ingredients included.TheVoiceOfHealthRadio.com

VIDEOS: 1. The Anti-Smartphone Revolution – (13:23) ColdFusion 2. Gravitas Plus: Explained: The China-Taiwan conflict (9:11)   HEALTH NEWS Astonishing effects of grapes, remarkable potential for health benefits Frequent nut consumption associated with less inflammation Body posture affects how oral drugs absorbed by stomach [why not supplements too?]  Lifting Weights Beats Out Cycling, Swimming For Vegans Wanting Stronger Bones Perfectionism Linked To Burnout At Work, School And Sports, Research Finds  Mindfulness Therapy Better Than Antidepressants Astonishing effects of grapes, remarkable potential for health benefits Western New England University, August 8, 2022 Recent studies released by Dr. John Pezzuto and his team from Western New England University show “astonishing” effects of grape consumption and “remarkable” impacts on health and on lifespans. Published in the journal Foods, one study showed that adding grapes in an amount equal to just under two cups of grapes per day to a high-fat diet, typically consumed in western countries, yielded reductions in fatty liver and extended lifespans.  Noting that these studies add an entirely new dimension to the old saying ‘you are what you eat,' Pezzuto, who has authored over 600 scientific studies, said that the work with grapes showed actual changes in genetic expression. “That is truly remarkable.” Adding grapes to a high-fat diet also increased levels of antioxidant genes and delayed natural death.  Acknowledging that it is not an exact science to translate years of lifespan from a mouse to a human, Pezzuto said that his best estimate is the change observed in the study would correspond to an additional 4-5 years in the life of a human. Another study by Dr. Pezzuto and his team published in the journal Antioxidants, reported that grape consumption altered gene expression in the brain and had positive effects on behavior and cognition that were impaired by a high-fat diet.  Frequent nut consumption associated with less inflammation Brigham and Women's Hospital, August 1, 2022 In a study of more than 5,000 people, investigators from Brigham and Women's Hospital have found that greater intake of nuts was associated with lower levels of biomarkers of inflammation, a finding that may help explain the health benefits of nuts. The results of the study appear in the American Journal of Clinical Nutrition. “Population studies have consistently supported a protective role of nuts against cardiometabolic disorders such as cardiovascular disease and type 2 diabetes, and we know that inflammation is a key process in the development of these diseases,” said corresponding author Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine. “Our new work suggests that nuts may exert their beneficial effects in part by reducing systemic inflammation.” In the current study, the research team performed a cross-sectional analysis of data from the Nurses' Health Study, which includes more than 120,000 female registered nurses, and from the Health Professionals Follow-Up Study, which includes more than 50,000 male health professionals. The team assessed diet using questionnaires and looked at the levels of certain telltale proteins known as biomarkers in blood samples collected from the study participants. They measured three well-established biomarkers of inflammation: C-reactive protein (CRP), interleukin 6 (IL6) and tumor necrosis factor receptor 2 (TNFR2). After adjusting for age, medical history, lifestyle and other variables, they found that participants who had consumed five or more servings of nuts per week had lower levels of CRP and IL6 than those who never or almost never ate nuts. In addition, people who substituted three servings per week of nuts in place of red meat, processed meat, eggs or refined grains had significantly lower levels of CRP and IL6. Peanuts and tree nuts contain a number of healthful components including magnesium, fiber, L-arginine, antioxidants and unsaturated fatty acids such as α-linolenic acid.  Body posture affects how oral drugs absorbed by stomach [why not supplements too?]  Johns Hopkins School of Medicine, August 8, 2022 A common, economic, and easy method of administering drugs is orally, by swallowing a pill or capsule. But oral administration is the most complex way for the human body to absorb an active pharmaceutical ingredient, because the bioavailability of the drug in the gastrointestinal tract depends on the medication's ingredients and the stomach's dynamic physiological environment. In Physics of Fluids, researchers from Johns Hopkins School of Medicine employ a biomimetic in-silico simulator based on the realistic anatomy and morphology of the stomach—a “StomachSim”—to investigate and quantify the effect of body posture and stomach motility on drug bioavailability. “”When the pill reaches the stomach, the motion of the stomach walls and the flow of contents inside determine the rate at which it dissolves. The properties of the pill and the stomach contents also play a major role. Stomach contents, motility, and gastric fluid dynamics all play a role in a drug's bioavailability, and stomach contractions can induce pressure and generate complex pill trajectories. This results in varying rates of pill dissolution and nonuniform emptying of the drug into the duodenum and, sometimes, gastric dumping in the case of modified-release dosage. The modeling appears to be the first of its kind to couple gastric biomechanics of posture with pill movement and drug dissolution to quantify an active pharmaceutical ingredientpassing through the pylorus into the duodenum. The model enabled the researchers to calculate and compare the emptying rate and the release of a dissolved active pharmaceutical ingredient into the duodenum for a variety of physiological situations. Lifting Weights Beats Out Cycling, Swimming For Vegans Wanting Stronger Bones Medical University of Vienna (Austria), August 2, 2022 When it comes to bone health, a new study finds people on a plant-based diet should grab the dumbbells. Researchers in Austria have found that lifting weights is the best form of exercise for vegans – trumping cycling and swimming. The team found that vegans who do resistance training once a week – such as machine-work, free weights, or bodyweight resistance – have stronger bones than plant-based eaters who do other forms of exercise. The new study, published in the Journal of Clinical Endocrinology & Metabolism, found vegans who did resistance training had similar bone structure to omnivores — people who eat both meat and vegetables. For at least five years, authors followed 43 men and women on a plant-based diet and 45 men and women who eat meat as well. “Our study showed resistance training offsets diminished bone structure in vegan people when compared to omnivores.” Perfectionism linked to burnout at work, school and sports, research finds  York St. John University (UK), July 31, 2022 Concerns about perfectionism can sabotage success at work, school or on the playing field, leading to stress, burnout and potential health problems, according to new research published by the Society for Personality and Social Psychology.  In the first meta-analysis of the relationship between perfectionism and burnout, researchers analyzed the findings from 43 previous studies conducted over the past 20 years. It turns out perfectionism isn't all bad. One aspect of perfectionism called “perfectionistic strivings” involves the setting of high personal standards and working toward those goals in a pro-active manner. These efforts may help maintain a sense of accomplishment and delay the debilitating effects of burnout, the study found.  The dark side of perfectionism, called “perfectionistic concerns,” can be more detrimental when people constantly worry about making mistakes, letting others down, or not measuring up to their own impossibly high standards, said lead researcher Andrew Hill, an associate professor of sport psychology at York St. John University in England. Previous research has shown that perfectionistic concerns and the stress they generate can contribute to serious healthproblems, including depression, anxiety, eating disorders, fatigue and even early mortality. The study was published online in the Personality and Social Psychology Review. The study found that perfectionistic concerns had the strongest negative effects in contributing to burnout in the workplace, possibly because people have more social support and clearly defined objectives in education and sports. A student can be rewarded for hard work with a high grade, or a tennis player can win the big match, but a stellar performance in the workplace may not be recognized or rewarded, which may contribute to cynicism and burnout.  “People need to learn to challenge the irrational beliefs that underlie perfectionistic concerns by setting realistic goals, accepting failure as a learning opportunity, and forgiving themselves when they fail,” Hill said. “Creating environments where creativity, effort and perseverance are valued also would help.”  Mindfulness Therapy Better Than Antidepressants University of Exeter (UK), July 31, 2022  Antidepressants are big business.  But for the same money, and without the side effects, a little mindfulness can do the same job.  A new study from the University of Exeter in the UK suggests that mindfulness-based cognitive therapy (MBCT) is just as good as drugs – and maybe even better   MBCT is a structured training program for the mind and body.  It was developed to help people deal with repeated bouts of depression.  It teaches them skills to recognize and respond constructively to the thoughts and feelings associated with relapse.  In other words, it helps patients re-focus their thoughts as a way to avoid falling back into depression. Prior studies have shown that MBCT reduces the risk of relapse or recurrence of depression by about 34% compared to usual care or placebo.  B The research published in The Lancet  followed a group of 424 depressed patients for two years. The patients had all suffered three or more previous major depressive episodes.  And they were all taking a maintenance course of antidepressants. The MBCT group attended eight group therapy sessions in which they learned mindfulness practices and cognitive-behavioral skills, and participated in group discussions.   After two years, relapse rates were worse in the drug group.  The drug group relapsed at the rate of 47% compared to only 44% for the mindfulness group.  The researchers concluded that MBCT may be an effective alternative to antidepressants for prevention of depressive relapse with no significant difference in cost. And it may be a good alternative for people who choose not to use drugs.  But they also suggested MBCT was more beneficial than drugs in preventing relapses in patients who were at highest risk of relapse especially those who reported severe childhood abuse.

Las maniobras militares en torno a Taiwán permiten a China desplegar su poderío militar y desafiar la hegemonía de EEUU en esa región. Un estudio publicado en The Lancet revela que uno de cada ocho enfermos de Covid padece secuelas a largo plazo. Y Rusia estudia un intercambio de presos tras condenar a la jugadora de baloncesto estadounidense Brittney Griner por narcotráfico.

Welcome to a special bonus episode celebrating the 29th ANNUAL CANADIAN GRAND PRIX NEW PRODUCT AWARDSSylvain and I are thrilled to be a sponsor of these prestigious awards for the third year in a row and have the chance to hand out the hardware on the stage to the winners in person for the first time!We had the opportunity to meet and get to know many fantastic food innovators and entrepreneurs, creators and makers - from consumer brands to private retail labels.   These are their stories.In this episode, meet  Mary Peluso, Director, Private Label Grocery, SobeysThanks for joining us on this special bonus episode of The Food Professor. Stay tuned for plenty of great interviews of the finalists from the Retail Council of Canada's Canadian Grand Prix New Product Awards. And stay tuned for our regular full-length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.  About MaryA highly motivated, energetic individual with an extensive background in buying, planning and omni merchandising. I have led successful teams in both the retail and wholesale markets. My diverse background has given me commodity experience in all industries including : health and beauty, grocery and hardlines.About UsDr. Sylvain Charlebois Dr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability. He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star. Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa. Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

Over the last several years, the “limit of viability” for neonates has decreased dramatically. The new “lower limit” of neonatal viability can now be considered to be as early as 22 gestational weeks. But there's a lot more to that statement! In this session, we will review the latest data on neonatal survival in the Periviable interval. We will highlight and summarize a new publication from the Lancet published on July 25, 2022. Should we be performing “universal resuscitation” at 22 weeks? Or should we take a more “selective” approach? Let's summarize the latest data.

Today our English listening practice topic is about depression, anti-depressants and serotonin. A recent research paper says serotonin has little or nothing to do with depression! So wait a minute, the primary treatment we have to help people with depression targets serotonin, and serotonin has little or nothing to do with depression. How could we possibly take so long to discover something this fundamental? With so many people taking these pills, there is a lot to talk about. ✔Lesson transcript: https://adeptenglish.com/lessons/english-listening-practice-serotonin-depression/ English Listening Practice: Serotonin Imbalance Does Not Cause Depression Anti-depression medication affects the people who take it. Otherwise, why prescribe the drugs to so many people and for such long periods of time? People will tell you that anti-depressant pills have helped them, but whatever is going on medically is now being questioned by some heavyweight medical research from University College London. Of course, this ignores the elephant in the room, and that is the side effects of taking this type of mind-altering drug over long periods of time. English Pronunciation Course Discount Code = HALFOFF Listen & Learn English Consonants Pronunciation Course: https://adeptenglish.com/language-courses/listen-and-learn-english-consonants-pronunciation-course/ When I say a lot of people take these pills, I mean millions of people in Britain alone! The Lancet published data from NHS Digital showing that 70.9 million prescriptions for antidepressants were given out in England in 2018, compared with 36 million in 2008. No wonder the anti-depression pill market is booming. The global antidepressant drugs market in 2020 had a value of 15.6 Billion USD and they project it will reach 21 Billion USD by 2030. It's a substantial business if you are one of the 5 major players that dominates this market. Since I was 16, I've felt a black cloud hangs over me. Since then, I have taken pills for depression. ⭐ Amy Winehouse, UK Singer Now tell me that this English listening lesson isn't engaging! We want you to want to listen to the content, to make it worth the struggle to understand the English vocabulary. It's this type of value content you will find in all our English lessons. Learn English through listening, it's a better way to learn to speak English fluently.

In this episode Kristi Milley continues her conversation with Professor Jon Emery, Herman Chair of Primary Care Research at the University of Melbourne, and Director of PC4. And Professor Michael Jefford, Medical Oncologist and Director of the Australian Cancer Survivorship Centre at the Peter MacCallum Centre. Jon and Michael are part of a team of experts who have published a series of three papers around Cancer Survivorship in the Lancet. And for those of you who aren't in research, The Lancet would be the silver medallist at the Olympics in medical journals. Today, we're discussing the first two papers in the series: management of clinical issues experienced by survivors, and improved models of care for cancer survivors.

Hello and welcome to the Alcohol Alert, brought to you by The Institute of Alcohol Studies.In this edition:Shift in England’s drinking during COVID-19 could lead to 150,000 more cases of disease by 2035 🎵 Podcast feature 🎵The global burden of poor analysisMinimum pricing has never been promoted as a panaceaPubs: “lost forever” or consolidated?Health Disparities white paper delayedBoris Johnson “minimises” sexual harassment and blames alcoholIndustry arguments dominate Commons debate on alcohol tax reformAlcohol packaging captures the attention of and creates appeal among young peopleAlcohol Toolkit Study: updateWe hope you enjoy our roundup of stories below: please feel free to share. Thank you.IAS BlogsTo read blogs click here.Shift in England’s drinking during COVID-19 could lead to 150,000 more cases of disease by 2035 🎵 Podcast feature 🎵A new IAS and HealthLumen modelling study suggests changes in alcohol consumption during the COVID-19 pandemic are likely to lead to thousands of additional cases of diseases and premature deaths.The pandemic saw heavier drinkers consuming more alcohol and this trend is continuing. If consumption does not return to 2019 levels or lower, England could see an additional 147,892 cases and 9,914 additional premature deaths from nine alcohol-related diseases, costing the NHS £1.2bn.Three scenarios were modelled between 2022 and 2035 to project how recent changes in drinking may affect health harm from nine alcohol-related diseases: high blood pressure, stroke, liver cirrhosis, and six forms of cancer. The research found:Joint Lead on the study Dr Sadie Boniface said:“Much of the health harm from alcohol is from chronic diseases which take years to develop. Our results shed light on the long-term impacts of recent changes in drinking patterns.“These increases in alcohol harm, lives lost, and costs to the NHS projected in our study are not inevitable.“Deaths from alcohol are at record levels, and this research should act as a ‘wake-up call’ to take alcohol harm seriously as part of recovery planning from the pandemic.”A very similar modelling study by the University of Sheffield was published at the same time and backed up IAS’ findings. The Sheffield study looked at more diseases across a longer period of time, so projected higher alcohol-related deaths and hospital admissions.Dr Boniface was interviewed on the BBC News, explaining the study findings and implications:If you missed our launch webinar, where Dr Boniface and Sheffield’s lead author Colin Angus presented their studies, you can catch up on YouTube here.The global burden of poor analysisIn mid-July, a new Global Burden of Disease (GBD) study was published in The Lancet. The GBD study is a long-running observational epidemiological study. Their new publication was widely covered in the media with most either stating that “alcohol is never good for people under 40” or “Young people should not drink alcohol but older people may benefit from small amounts”.The study found that for men aged 15-39, the recommended amount of alcohol before “risking health loss” was just 0.136 of a standard drink a day. For women of the same age, the “theoretical minimum risk exposure level” was 0.273 drinks – about a quarter of a standard drink a day.Among those aged 40-64, safe alcohol consumption levels ranged from about half a standard drink a day to almost two standard drinks. For those aged 65 or older, the risks of “health loss from alcohol consumption” were reached after consuming a little more than three standard drinks a day.The senior author, Dr Emmanuela Gakidou, professor of health metrics sciences at the University of Washington’s School of Medicine, said:“Our message is simple: young people should not drink, but older people may benefit from drinking small amounts.”This is in contrast to their study four year ago, which said that even the occasional drink was harmful to health and suggested governments should advise people to abstain entirely.Colin Angus wrote an IAS blog criticising elements of the study, for instance the study saying “older people may benefit from drinking small amounts” could be seen to suggest non-drinking older people should take up drinking for its supposed protective effects. Another major issue he flagged was that the study tells you “absolutely nothing about the difference in risks between age groups or the absolute risks that people are facing as a consequence of their drinking”.In the media Mr Angus said:“Younger people are, on average, much less likely to become ill or die from any cause than their older counterparts. Assessing how we should set drinking guidelines or prioritise interventions to minimise the total harm of alcohol requires an assessment of absolute, not relative risk.“The GBD’s own figures suggest that there are over 14 times as many alcohol-attributable deaths in the UK among 70-74 year-olds than 20-24 year olds, which rather contradicts the assertion in this new study that we should focus on the drinking of younger age groups.”Statistician Sir David Spiegelhalter also criticised the study on Twitter:Minimum pricing has never been promoted as a panaceaIn the 22nd of July’s BMJ Editorial, IAS’ Dr Sadie Boniface discussed the new WHO report on minimum pricing policies for alcohol, explaining the report structure and stating that minimum pricing “is an effective part of the policy toolbox for reducing harm from alcohol”.Following a number of recent reports that minimum pricing has failed in Scotland, Dr Boniface writes in the Editorial:“Minimum pricing has never been promoted as a panacea, so arguments that it does not singlehandedly eliminate harm from alcohol can be rejected. Proponents do not claim, for example, that minimum pricing is enough to reduce alcohol consumption and harm among people who are dependent on alcohol, for whom the wider healthcare and support needs are obvious. Minimum pricing is one policy in the toolbox, needed alongside others as part of a coherent strategy.”Dr Boniface discusses what a coherent policy landscape would look like, with population level policies implemented, effectively monitored and evaluated, alongside a suitably resourced and accessible healthcare system offering support. She explains that policies have to be independent from industry influence, an influence which remains a major challenge to a coherent approach.Pubs: “lost forever” or consolidated?According to real estate consultancy Altus Group, there were 39,970 pubs in June, down by more than 7,000 since 2012. Altus said after struggling through Covid the industry now faces soaring prices and higher energy costs.Altus said that pubs which had "disappeared" from the communities they once served had either been demolished or converted for other purposes, meaning that they were "lost forever".A 2017 IAS publication found publicans often attributed pub closures to failures of their managers who are unable to respond to shifting consumer expectations. It also found supermarkets undercutting pubs in price was the major threat to pubs’ commercial viability. As shown below, the gap between on and off-trade consumption has been steadily widening for many years:Another reason for pub closures is consolidation of business into bigger bars. This ONS report in 2018 showed that while small pubs were closing, big pub chains were consolidating business, with employee numbers and overall revenue remaining relatively constantThe Government said:"We've cut taxes for hundreds of thousands of businesses by increasing the Employment Allowance while slashing fuel duty. We've also introduced a 50% business rates relief for eligible High Street businesses and prevented bill increases by freezing the business rates multiplier, saving businesses £4.6bn over the next five years."Health Disparities white paper delayedThe Health Disparities white paper – due to be published in late July – has been delayed for the summer and will only go ahead if given the green light by the new Prime Minister.The white paper is set to include further legislation to increase alternatives to tobacco products and increase alcohol-free products in pubs.An ITV article said:“In recent weeks charities and other health groups have been pushing for the paper to introduce preventative measures and measures that have a population wide focus. Sources said there was a risk that a future pm could drop this agenda - although pointed out that the policies had been framed as "non-nanny state" - perhaps to try to make sure it had Cabinet support.”The white paper is said to include a change to the classification of no and low alcohol beers. Currently no-alcohol has to be 0.5% or lower and low-alcohol 1.2% or lower. This could rise to 1% and 3% respectively.The change is said to be designed to help people cut down alcohol consumption “by helping brewers make low-strength options more appealing”.Professor Sir Ian Gilmore, chair of the AHA, suggested that more evidence was needed on low-alcohol products but said “if it could be done in a way without brand promotion, we would be supportive”.However, Gilmore said the plan was “tinkering round the edges” and that the government had “consistently put its head in the sand on evidence-based policies that have been shown worldwide to reduce harm”, mainly by increasing prices and reducing availability.Boris Johnson “minimises” sexual harassment and blames alcoholWhile being question by the Liaison Committee about his handling of the conduct of former deputy chief whip Chris Pincher, Boris Johnson said there’s a problem with alcohol in Westminster and that “some people simply can’t take their drink”.Conservative committee member Caroline Nokes MP asked him “have you just sat there and told us that alcohol is an excuse?”, to which Boris disagreed.In the resignation letter of parliamentary private secretary Mark Fletcher, he wrote about the Pincher assault:“You suggested that the events of that night were the fault of the colleagues who were present for allowing him to drink too much. Such a view seems to me an attempt to absolve Mr Pincher of his actions and, in so doing, to be an apologist for someone who has committed sexual assault.”Ian Hamilton, of the University of York, wrote in the Independent that alcohol should not be used as an excuse for predatory sexual behaviour as this displaces responsibility from the perpetrator. He wrote:“While the victim is left with the impression that it was the drug rather than the person responsible, the perpetrator tries to evade taking responsibility for what they did. This hardly gives anyone hope that this predatory behaviour will change. Even if predators become abstinent from alcohol, this won’t magically displace their thought processes and perception about what is permissible and what isn’t, in relation to others.”Industry arguments dominate Commons debate on alcohol tax reformOn 7 July the Commons debated the proposed reform to alcohol duty, with discussion of its impact on the alcohol industry – particularly the wine industry – dominating proceedings.Welsh Conservative Alun Cairns opened the debate and asked for “minor adjustments” to the strength bands and Small Brewers’ Relief.Various other MPs spoke of the new system being too complicated, with too many tax bands, and how wine producers will find it difficult as wine strength is dependent on the weather.Liberal Democrat MP Daisy Cooper said: “Overall, the alcohol duty reforms proposed by the Government just tinker around the edges in dealing with the pressures facing hospitality”, seemingly not recognising the importance of the public health element of the reform.Shadow Exchequer Secretary, Abena Oppong-Asare MP, said Labour agrees the system should be simplified and be more consistent, and be balanced across public health and supporting business. She said the wine bands should be looked at, as the new system has too much red tape, as should changes to beer duty which currently would help bigger brewers more than small brewers.Oppong-Asare went on to point out the cider exceptionalism, with it having a lower rate than beer in the proposals, and asked the Treasury to explain why this is when strong cheap cider causes so much harm.Financial Secretary to the Treasury, Lucy Frazer MP responded to the majority of the concerns and said they will be looked into. She did highlight that public health was a major reason for the reform. Alcohol packaging captures the attention of and creates appeal among young peopleA new Stirling study has highlighted the impact alcohol packaging has on capturing the attention of and creating appeal among young people.50 current drinkers aged 18-35 participated in 8 focus groups, in which they were asked about a range of alcoholic products.Daniel Jones, the lead author, said:“Five main themes emerged from our data: the ubiquity of alcohol packaging; its appeal and ability to catch attention; its association with particular occasions and activities; its ability to inform perceptions; and its engagement of both visual and non-visual senses – taste, touch, sound and smell.”Notably, some participants reported purchasing alcohol products solely on pack appeal, with one saying: “I don’t actually like beer, but I bought it specifically because I liked the packaging”.Drinkers preferred exclusive-looking “limited edition” packaging over large price marks portraying the drink as value for money, as they felt value drinks were inferior. Most retained expensive or “cool” empty bottles for display or collection.Matt Lambert of the Portman Group said:“This study demonstrates that the packaging of a product is designed to appeal to different audiences, something that would ring true across all forms of marketing and is not in itself a surprise.”He added that the group's code of practice ensures alcohol is not marketed inappropriately and highlighted how adherence to the code had contributed to “over a decade of decline in underage drinking in Scotland”.Alcohol Toolkit Study: updateThe monthly data collected is from English households and began in March 2014. Each month involves a new representative sample of approximately 1,700 adults aged 16 and over.See more data on the project website here.Prevalence of increasing and higher risk drinking (AUDIT-C)Increasing and higher risk drinking defined as those scoring >4 AUDIT-C. A-C1: Professional to clerical occupation C2-E: Manual occupationCurrently trying to restrict consumptionA-C1: Professional to clerical occupation C2-E: Manual occupation; Question: Are you currently trying to restrict your alcohol consumption e.g. by drinking less, choosing lower strength alcohol or using smaller glasses? Are you currently trying to restrict your alcohol consumption e.g. by drinking less, choosing lower strength alcohol or using smaller glasses?All past-year attempts to cut down or stopQuestion: How many attempts to restrict your alcohol consumption have you made in the last 12 months (e.g. by drinking less, choosing lower strength alcohol or using smaller glasses)? Please include all attempts you have made in the last 12 months, whether or not they were successful, AND any attempt that you are currently making.The UK Alcohol Alert (incorporating Alliance News) is designed and produced by The Institute of Alcohol Studies. Please click the image below to visit our website and find out more about us and what we do, or the ‘Contact us’ button. Thank you. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit instalcstud.substack.com

"What is happening right now with teens and drug use is unprecedented and historically we have never seen anything like this." -Dr. Joseph Friedman  Dr. Friedman sits down with Dr. Bob for a very important conversation about the alarming increase in teen overdose deaths related to fentanyl - especially in the last two years (fentanyl is being found in counterfeit drugs, which is very deadly). Dr. Friedman walks us through important, thorough information for parents about drug education for teens and how the knowledge could save a life.  Don't miss this critical conversation! Joseph Friedman, PhD, MPH, is a substance use researcher at UCLA and a trainee in the UCLA MSTP program. He completed a PhD in Social Medicine at the UCLA Center for Social Medicine and Humanities, and a master's degree in public health from the University of Washington, focused on Global Health Metrics. Much of his current research focuses on the North American overdose crisis, tracking rapidly emerging trends and social inequalities. His peer-reviewed academic work has been published in journals including JAMA, Nature, and The Lancet, and his popular press writings have appeared in venues such as the Los Angeles Times and Time Magazine.  How to contact Dr. Joseph Friedman: Twitter Linktree Google Scholar How to contact Dr. Bob: Dr. Bob on YouTube: https://www.youtube.com/channel/UChztMVtPCLJkiXvv7H5tpDQ Dr. Bob on Instagram: https://www.instagram.com/drroberthamilton/ Dr. Bob on Facebook: https://www.facebook.com/bob.hamilton.1656 Dr. Bob on Instagram: https://www.instagram.com/drroberthamilton/ Dr. Bob on Facebook: https://www.facebook.com/bob.hamilton.1656 Dr. Bob on Instagram: https://www.instagram.com/drroberthamilton/ Dr. Bob on Facebook: https://www.facebook.com/bob.hamilton.1656

Mandip Aujla talks to Binita Kane, co-founder of South Asian Heritage Month, about South Asian culture, history, and community, and the two new chairs of the Lancet's Group for Racial Equality discuss the group's work on diversity and inclusion.Find out more about South Asian Heritage Month hereYou can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @GavinCleaver.

Welcome to a special bonus episode celebrating the 29th ANNUAL CANADIAN GRAND PRIX NEW PRODUCT AWARDSSylvain and I are thrilled to be a sponsor of these prestigious awards for the third year in a row and have the chance to hand out the hardware on the stage to the winners in person for the first time!We had the opportunity to meet and get to know many fantastic food innovators and entrepreneurs, creators and makers - from consumer brands to private retail labels.   These are their stories.In this episode, meet Jim Delsnyder, Chief Operating Officer, Zoglo'sThanks for joining us on this special bonus episode of The Food Professor. Stay tuned for plenty of great interviews of the finalists from the Retail Council of Canada's Canadian Grand Prix New Product Awards. And stay tuned for our regular full-length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.  About JimJim has been a leader in the Food and Beverage industry for more than 20 years. He was the former president of Eska Water Inc for 9 years and has worked at many other reputable companies such as Nestle Waters and Quaker Oats. About UsDr. Sylvain Charlebois Dr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability. He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star. Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa. Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

In this episode, Marc and Mo discuss 3 recent articles that caught their eye. The first part of the discussion focuses on the importance of blinded assessment of outcomes in clinical trials, and the second part focuses on the use of tranexamic acid in patients with hip fractures. Links: Metcalfe A, Parsons H, Parsons N, Brown J, Fox J, Gemperlé Mannion E, Haque A, Hutchinson C, Kearney R, Khan I, Lawrence T, Mason J, Stallard N, Underwood M, Drew S; START:REACTS team. Subacromial balloon spacer for irreparable rotator cuff tears of the shoulder (START:REACTS): a group-sequential, double-blind, multicentre randomised controlled trial. Lancet. 2022 May 21;399(10339):1954-1963. doi: 10.1016/S0140-6736(22)00652-3. Epub 2022 Apr 21. PMID: 35461618. https://bit.ly/3P62z0I Verma N, Srikumaran U, Roden CM, Rogusky EJ, Lapner P, Neill H, Abboud JA; SPACE GROUP. InSpace Implant Compared with Partial Repair for the Treatment of Full-Thickness Massive Rotator Cuff Tears: A Multicenter, Single-Blinded, Randomized Controlled Trial. J Bone Joint Surg Am. 2022 Apr 22. doi: 10.2106/JBJS.21.00667. Epub ahead of print. PMID: 35777921. https://bit.ly/3cBTmz6 Porter SB, Spaulding AC, Duncan CM, Wilke BK, Pagnano MW, Abdel MP. Tranexamic Acid Was Not Associated with Increased Complications in High-Risk Patients with Intertrochanteric Fracture. J Bone Joint Surg Am. 2022 Jul 6;104(13):1138-1147. doi: 10.2106/JBJS.21.01389. Epub 2022 Apr 29. PMID: 35775092. https://bit.ly/3AHrhjT POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12. PMID: 18479744. https://pubmed.ncbi.nlm.nih.gov/18479744/ Subspecialties: Shoulder Trauma Hip Orthopaedic Essentials

Date: July 22nd, 2022 Reference: Perry et al. Immobilisation of torus fractures of the wrist in children (FORCE): a randomised controlled equivalence trial in the UK. The Lancet 2022 Guest Skeptic: Dr. Tessa Davis is a Paediatric Emergency Consultant at the Royal London Hospital, Senior Lecturer at Queen Mary University of London, Co-founder of Don't Forget The […]

A study published this week in The Lancet found that people under 40 shouldn't drink alcohol at all. This was a big study that looked at a lot of data, so in this episode Gill explains where the data came from, what they focused their analysis on, and the outcomes. Since this study is calling for the guidelines to be revisited, she also explains how the guidelines are even determined in the first place. You'll learn about the limits of this study, some criticisms about its conclusions, and how studies on alcohol and health are normally performed. What to listen to next:E85: Biased Alcohol Studies vs RealityE90: New Study Finds Just One Drink Shrinks Your Brain, or Does it?E95: Surprise, Moderate Drinking Isn't Good for Your Heart (New Study)E63: Why Alcohol Causes Depression and Suicidal ThoughtsE65: What Happens to the Body When You Binge DrinkSign up to get emails from me. I send out a preview of the next podcast episode, discount codes, and new announcements every Thursday.Check out my YouTube channel.  Please subscribe! Sources are posted here.Follow Sober Powered on Instagram for more education and inspirationJoin the Sober Powered Facebook Group for extra supportAnd if you're enjoying this podcast, please consider leaving a review on Apple Podcasts/iTunes. This podcast takes so much effort and work to create, and each review increases the possibility that this podcast can be seen by people who may need it.  Disclaimer: all of the information described in this podcast is my interpretation of the research combined with my opinion. This is not medical advice.Soberlink is offering you $50 off an alcohol monitoring system that includes a breathalyzer device with facial recognition that allows you to share your sobriety in real time. Soberlink has also created a free resources guide specifically for Sober Powered listeners “How to Hold Yourself Accountable in Early Recovery”. Use this link to get your copy of the guidehttps://bit.ly/3Bp2krxSupport the show

Welcome to another special SIAL bonus episodes of The Food Professor podcast!Sylvain and I were thrilled to be the official podcast of the SIAL food innovation trade show held in Montreal in April. We had the opportunity to meet and get to know many food innovators and entrepreneurs, creators and makers from many facets of the food industry.   These are their stories.In this episode:  Meet  Sylvain Roux, CEO, and Philippe Begin, Vice President, Dauphinais Thanks for joining us on this special bonus episode of The Food Professor.  Stay tuned for plenty of great interviews from our podcast studio on the trade show floor in Montreal at SIAL, and stay tuned for our regular full length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.   About UsDr. Sylvain CharleboisDr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability.He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star.Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa.Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

I vårt moderna samhälle har döden alltmer flyttat in på sjukhuset, bort från de anhöriga. Döden har blivit "övermedikaliserad" menar forskare i en ny rapport. Hur kan vår sista tid bli en värdefull del av livet? Programmet är en repris från 31 maj 2022.Något har gått fel med hur vi dör och hur vi hanterar andras död i vårt moderna samhälle, enligt ledande forskare i en rapport från en kommission kopplad till tidskriften the Lancet. Och de som arbetar med vår sista tid i livet menar själva att yrkesmänniskorna har fått en alltför stor roll. Vi anhöriga och vår kärlek till den döende kan sägas ha fastnat i väntrummet, samtidigt som stora resurser går åt till avancerad vård som inte kan rädda patienten. Hur kan då den sista tiden i livet bli bättre för den som ska dö, för de anhöriga, och för samhället? - Det är viktigt att den sista delen av livet är just en del av livet! Många i samhället förknippar palliativ vård med döden, och tänker att inget finns att göra. Det är tvärtemot hur vi i den palliativa vården tänker och gör, där vi vill möjliggöra ett liv så länge som möjligt, säger Joakim Öhlén, expert på palliativ vård, alltså vård i livets slutskede.- Vi i Sverige har en attityd av OM vi dör som skapar en distans till döden, och ger en illusion av att det är vi som har kontroll över liv och död, säger Sara Möller, verksamhetschef på Bräcke hospice i Göteborg.Medverkande: Joakim Öhlén, professor i omvårdnad vid Sahlgrenska akademin, sjuksköterska på palliativt centrum på Sahlgrenska universitetssjukhuset och föreståndare för centrum för personcentrerad vård vid Göteborgs universitet; Libby Sallnow, forskare University college London Hospitals och Vrije Universiteit i Belgien, och medförfattare till Lancetkommissionens rapport On the value of death: bringing death back into life; Heather Richardson, St Christophers Hospice, London; Sara Möller, verksamhetschef på Bräcke hospice i Göteborg.Reporter: Sara Heyman, korrespondent för global hälsa sara.heyman@sr.seProducent: Björn Gunér bjorn.guner@sr.se

Welcome to a special bonus episode celebrating the 29th ANNUAL CANADIAN GRAND PRIX NEW PRODUCT AWARDSSylvain and I are thrilled to be a sponsor of these prestigious awards for the third year in a row and have the chance to hand out the hardware on the stage to the winners in person for the first time!We had the opportunity to meet and get to know many fantastic food innovators and entrepreneurs, creators and makers - from consumer brands to private retail labels.   These are their stories.In this episode, meet Canadian Grand Prix New Product Awards Finalist Bonus episode: Meet Rob Sengotta and Landon Kroeker, Von Slick's Finishing TouchThanks for joining us on this special bonus episode of The Food Professor. Stay tuned for plenty of great interviews of the finalists from the Retail Council of Canada's Canadian Grand Prix New Product Awards. And stay tuned for our regular full-length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.  About Rob Sengotta and Landon KroekerThe Man Behind the Flavour: RobMy 25 year culinary career has been an experience filled with adventure and growth. From world travel to building amazing relationships and pushing myself out of my comfort zone to continue to master my craft.I've had the privilege of cooking on private yachts, fine dining trains, even at a Helicopter ski resort.  Working with some of the best chefs in Europe and Canada along the way.From Michelin star restaurants in England and France, to spending time as a private chef in Whistler and Vancouver and finally owning my own fine dining restaurant for 10 years in British Columbia's beautiful Shuswap region.Using compound butters in fine dining is a common occurrence to bring bold flavour to your dish, as well as create dish consistency. Yet it can be difficult to find the product on the retail level.From a home cook to professional chef, Von Slick's has the ability to deliver a new level of restaurant quality flavour to any of your home-cooked meals. About UsDr. Sylvain Charlebois Dr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability. He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star. Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa. Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

每日英語跟讀 Ep.K398: Omicron less likely to cause long COVID — UK study   The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the UK. 英國一項研究顯示，冠狀病毒之Omicron變異株跟之前的變種相比，較不易導致「長新冠」後遺症。這是首件經同儕審查的此類研究。 Researchers at King's College London, using data from the ZOE COVID Symptom study app, found the odds of developing long COVID after infection were 20 percent to 50 percent lower during the Omicron wave in the UK compared to Delta. The figure varied depending on the patient's age and the timing of their last vaccination. 倫敦大學國王學院研究人員分析應用程式「ZOE新型冠狀病毒疾病症狀研究」之資料，發現與Delta變異株相比，在英國這波Omicron疫情期間，感染後發生COVID後遺症的機率低了百分之二十至百分之五十，數字因患者之年齡及上一次接種疫苗的時間而異。 Long COVID, which includes prolonged symptoms ranging from fatigue to “brain fog,” can be debilitating and continue for weeks or months. It is increasingly being recognized as a public health problem, and researchers have been racing to find out if Omicron presents as big a risk of long COVID as previously dominant variants. COVID後遺症包括從疲倦到「腦霧」的長期症狀，可使人虛弱，並持續數週或數月。它越來越被認為是公共衛生問題，研究人員一直在努力找出Omicron的後遺症風險是否跟先前的主要變異株一樣高。 The study from King's is believed to be the first academic research to show Omicron does not present as great a risk of long COVID, but that does not mean long COVID patient numbers are dropping, the team said. 國王學院研究小組表示，此研究據信為第一項表明Omicron的COVID後遺症風險並不如此高的學術研究，但這不表示COVID後遺症患者的人數正在下降。 While the risk of long COVID was lower during Omicron, more people were infected, so the absolute number now suffering is higher. 雖然感染Omicron後導致COVID後遺症的風險較低，但因Omicron的感染人數更多，所以現在苦於此後遺症的絕對人數更高。 “It's good news, but please don't decommission any of your long COVID services,” lead researcher Dr Claire Steves told Reuters, appealing to health-service providers. 「這是個好消息，但請不要停止對COVID後遺症的任何治療」，研究計畫主持人克萊兒‧史帝芙斯博士在接受路透社訪問時，對醫療業提出此呼籲。 The UK's Office for National Statistics said in May that 438,000 people in the country have long COVID after Omicron infection, representing 24 percent of all long COVID patients. 英國國家統計局在五月表示，有四十三萬八千人在感染Omicron後患有COVID後遺症，佔英國所有COVID後遺症患者的百分之二十四。 It also said the risk of lingering symptoms after Omicron was lower than with Delta, but only for double-vaccinated people. It found no statistical difference for those who were triple vaccinated. 它還表示，感染Omicron後有持續症狀的風險低於感染Delta，但這只是對接種兩劑疫苗的人而言，而接種三劑疫苗的人在統計上並無差異。 In the King's research, 4.5 percent of the 56,003 people studied during Omicron's peak, December 2021-March 2022, reported long COVID. That compared to 10.8 percent of 41,361 people during the Delta wave, June-November 2021. It did not compare vaccinated and unvaccinated individuals. 國王學院在二○二一年十二月至二○二二年三月Omicron疫情高峰期間所研究的五萬六千零三人中，有百分之四點五的人表示有COVID後遺症。而在二○二一年六月至十一月的Delta變異株疫情期間所研究的四萬一千三百六十一人，有COVID後遺症的比例則為百分之十點八。此研究並未對疫苗接種者及未接種者做比較。 While the study — published in The Lancet journal on Thursday last week — compared Delta and Omicron, Dr Steves said previous work had showed no substantial difference in long COVID risk between other variants.More work was needed to establish why Omicron may have a lower long COVID risk, the team added. 雖然這項上週四發表於《刺胳針》期刊的研究比較了Delta及Omicron變異株的情況，但史帝芙斯博士表示，先前的研究顯示，其他變異株之間的COVID後遺症風險並無實質差異。 該研究小組補充說，Omicron的COVID後遺症風險可能較低之原因，需要做更多研究才能確定。Source article: https://www.taipeitimes.com/News/lang/archives/2022/06/28/2003780674

What if we knew which patients would have severe Crohn's disease or ulcerative colitis? And which wouldn't? How about if we could tell which drug would work best in which patient? Knowing these things would change how inflammatory bowel disease (IBD) is diagnosed and treated. Plus, more importantly: it would improve lives. Dr Andres Hurtado-Lorenzo, Vice President of Translational research and IBD Ventures at the Crohn's and Colitis Foundation explains biomarkers and how they may play into the future of how IBD is diagnosed, managed, and treated. Resources: Crohn's & Colitis Foundation:https://www.crohnscolitisfoundation.org/ IBD Plexus:https://www.crohnscolitisfoundation.org/research/current-research-initiatives/ibd-plexus/about RISK Study:https://www.crohnscolitisfoundation.org/research/current-research-initiatives/pediatric-risk-stratification IBD Ventures:https://www.crohnscolitisfoundation.org/research/grants-fellowships/entrepreneurial-investing/portfolio Olink: https://www.olink.com Foundation for the National Institutes of Health: https://www.fnih.org Genedata: https://www.com Glycominds: https://www.glycominds.com/blood-tests-1 PredictImmune:https://www.predictimmune.com/ Research: Honig G, Heller C, Hurtado-Lorenzo A. Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2020;26(10):1451-1462. doi:10.1093/ibd/izaa210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500521/pdf/izaa210.pdf Honig G, Larkin PB, Heller C, Hurtado-Lorenzo A. Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021;27(Suppl 2):S1-S16. doi:10.1093/ibd/izab230. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922161/pdf/izab230.pdf Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017;389(10080):1710-1718. doi:10.1016/S0140-6736(17)30317-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719489/pdf/nihms923305.pdf Biasci D, Lee JC, Noor NM, et al. A blood-based prognostic biomarker in IBD. Gut. 2019;68(8):1386-1395. doi:10.1136/gutjnl-2019-318343. https://www.predictimmune.com/wp-content/uploads/2020/09/Biasci-et-al-A-blood-based-prognostic-biomarker-in-IBD-Gut-2019.pdf de Bruyn M, Ringold R, Martens E, et al. The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor. J Crohns Colitis. 2020;14(2):176-184. doi:10.1093/ecco-jcc/jjz125. https://doi.org/10.1093/ecco-jcc/jjz125 Find Amber J Tresca at: com: http://aboutibd.com/ Verywell: https://www.verywell.com/ibd-crohns-colitis-4014703 Facebook: https://www.facebook.com/aboutIBD Twitter: https://twitter.com/aboutIBD Pinterest: https://www.pinterest.com/aboutibd/ Instagram: https://www.instagram.com/about_IBD/ Credits: Mix and sound design is by Mac Cooney: https://www.facebook.com/michaelandrewcooney Theme music, IBD Dance Party, is from ©Cooney Studio: https://michaelandrewcooney.bandcamp.com/track/ibd-dance-party-single

Long Story Short with Dr. Been Episode 15: Reduced Risk of Long COVID from Omicron As Compared to Delta Zoe app study printed in the Lancet demonstrates that in some cases the risk of long COVID in the Omicron era is 76% less than the long COVID in the Delta era. Let's review the data. DrBeen: Medical Education Online https://www.drbeen.com/ Home - FLCCC | Front Line COVID-19 Critical Care Alliance https://covid19criticalcare.com/ URL list from Friday, Jul. 1 2022 Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00941-2/fulltext#articleInformation Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2900941-2 Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

Nine Lancet journals are top of their categories for Impact Factor in the latest measurements. What is the value of Impact Factors? What do they capture, and what don't they capture? Richard Horton, editor-in-chief of The Lancet, joins Gavin and Jessamy to discuss impact.You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @GavinCleaver.

The Global Killer”, así le llamaron en la revista The Lancet a los siniestros viales que colocaron a los fallecimientos de este tipo como la octava causa de muerte en el mundo, según una serie de estudios publicada por cuatro investigadores expertos en seguridad vial y en salud pública.

THE THESIS: The Covid response Hoax is key to the Forever-Crisis The Party will use to install unfettered powers.  THE SCRIPTURE & SCRIPTURAL RESOURCES:  List Of 365 Fear Not Bible Verses THE NEWS & COMMENT: Dr. Zev Vladimir Zelenko's statement by Dr. Paul Elias Alexander on his death, in praise and recognition of a true hero, angel, and patriot; he had a place in the world to save lives and he did it! Letter to the U.K. Gov from 76 Doctors; Comprehensive reasons why the U.S. FDA decision authorizing COVID vaccinations in infants and young children must not happen in the UK. [AUDIO] - Two teenage boys from different states died in their sleep due to the second shot of Pfizer vaccine they had received a few days back. [AUDIO] - Fed's Jerome Powell blames Americans not getting vaccinated enough for his inflation crisis Here's former Surgeon General, Jerome Adams showing his boastful pride in the letters by his name as he is corrected, first by a Mom and, second--in defense of Adam's attack on that Mom--by Dr. Martin Kulldorff. As a Harvard professor I analyzed vaccine data for two decades and helped develop CDC's vaccine safety system. It's illuminating to realize that @KelleyKga, a mother with no science degree, understands epidemiological data better than former surgeon general @JeromeAdamsMD. Dr. Paul Alexander: “Portugal EU country highest vaccination rate; today has the most new Covid-19 cases; with most new daily deaths per million inhabitants; the COVID injection did not work, never worked, killing people; I argue the COVID injections never ever worked! The COVID injections are driving infectiousness of the omicron sub-variant; vaccinated getting severely infected, hospitalized and even death.” Here's what the Washington Post published about Portugal and the mRNA injections on 9-30-2021: Portugal has nearly run out of people to vaccinate. What comes next? Portugal's feat has turned the country into a cutting-edge pandemic laboratory — a place where otherwise-hypothetical questions about the coronavirus endgame can begin to play out. Chief among them is how fully a nation can bring the virus under control when vaccination rates are about as high as they can go.  The emerging answer is promising — mostly. In Portugal, every indicator of pandemic severity is quickly trending downward. The death rate is half the European Union average and nine times below that of the United States. Lisbon is triumphant: a city of live music and partying, where early-risers might find sidewalks still sticky with beer. Traffic is back to normal as people settle into the rhythms of commuting to work. And the celebrity of the moment — on glossy magazine covers — is the former submarine commander who led the country's vaccination drive. But Portugal's experience is also providing a note of caution: a reminder that 1½ years into this pandemic, the current tools of science still might not be enough. The virus is still causing cancellations, lost work days and sickness — in rare cases severe. It spreads less quickly and less far than it would in places with lower vaccination rates — which benefits everyone, including the 12-and-under children not yet eligible for shots. But herd immunity remains elusive. Daily calculations about risk remain, even without large ranks of unvaccinated people to blame. [AUDIO] - EU warns boosters may destroy immune system Dictator, Jay Inslee is requiring state workers in executive and small cabinets to get a COVID-19 booster shot as condition of employment. All state workers will be next. Not content with mandating masks on toddlers, enforcing discriminatory vaccine passports and his remarkable hypocrisy, the mayor of New York announced he will be mandating vaccines for children to attend school this fall. Dr. Paul Alexander: Australia, oh Australia, what is happening there July 1st 2022? Escalating infections, escalating deaths, 85-90% vaccinated!!! We told you idiots, stop the COVID injection, it is driving infection! Australia is talking masks again...they will not listen to Geert, or Yeadon, or Bridle, or I, yet they do not yet understand it is the virus-host ecosystem that is driving this; China, et tu? Et tu? [AUDIO - PAUSE] -  Working-Age Folks Disappearing Out of Nowhere: You Can't Blame This on COVID or Missed Cancer Screenings  -- Ed Dowd: You can't tell me the virus switched from only going after older folks to now going after younger folks and switching from respiratory to cardiovascular." While Dr. Ryan Cole is being attacked to the degree that he has lost half his business, the truth is still emerging . . . [AUDIO] - Prof. Jeffrey Sachs: "I chaired the commission for the Lancet for 2 years on Covid. I'm pretty convinced it came out of a US lab of biotechnology [...] We don't know for sure but there is enough evidence. [However] it's not being investigated, not in the US, not anywhere." Doctors who spoke truth are viciously attacked by the same media who continue to lie about all things Covid Politico, Axios, and NBC News peddle a weird Covid smear of Clarence Thomas Yikes... Washington Post "fact check" columnist @GlennKesslerWP  pushed Politico's fraudulent Clarence Thomas smear around Ironic how “Disinformation” experts and reporters always seem to be spreading so much of it themselves [AUDIO] - 100 year old veteran break down crying : "This is not the country we fought for" . . .  Remembering his time in the Marines, Carl Spurlin Dekle said that while fighting in the war was his biggest pride, soldiers had not died for the America of today See omnystudio.com/listener for privacy information.

Contributor: Peter Bakes, MD Educational Pearls: Lithium remains a commonly used medication for treating bipolar disorder Lithium toxicity can be acute, acute-on-chronic, or chronic  Measuring blood lithium level Therapeutic range of lithium is around 1.6-1.8 mEq/L >2 mEq/L is likely to cause significant toxicity >4 mEq/L necessitates lifesaving treatment The lethal dose of lithium is 700 mg/kg Lithium can have delayed absorption resulting in levels increasing during hospitalization Symptoms associated with acute lithium toxicity Gastrointestinal Nausea, vomiting, abdominal pain Neurological Tremor, nystagmus, CNS depression (late finding) Cardiovascular Bradycardia, QT prolongation, EKG changes Treatment for lithium toxicity ABCs Get a good history GI Decontamination: Whole bowel irrigation if patient ingested extended-release tablets Dialysis Most effective treatment for lithium toxicity References Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium Poisoning. J Intensive Care Med. 2017;32(4):249-263. Hedya SA, Avula A, Swoboda HD. Lithium Toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC.; 2022. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721-728.   Summarized by Mark O'Brien, MS4 | Edited by John Spartz, MD & Erik Verzemnieks, MD   The Emergency Medical Minute is excited to announce that we are now offering AMA PRA Category 1 credits™ via online course modules. To access these and for more information, visit our website at https://emergencymedicalminute.org/cme-courses/ and create an account.  Donate to EMM today!

Back in our March 2020 episode, This is Hope, we spoke with Dr. Larissa May about HIV screening in the ED. Screening programs, along with education and other resources, is making a difference, but there are still tens of thousands of new HIV cases in the U.S. each year, and probably 1-2 million new infections annually worldwide. There are clinical trials in progress studying potential HIV vaccines, which is exciting, but a widely available vaccine is still many years away. Luckily, we DO have a safe and effective way to help prevent new infections and transmission - pre-exposure prophylaxis (PrEP). Dr. Michael Casner joins us to share his expertise in all things PrEP, so we can help our patients stay safe and healthy.  Do you talk to your patients about PrEP? Does your ED have a way to connect patients with resources to obtain PrEP? Share your experience with us on social media, @empulsepodcast, via email empulsepodcast@gmail.com, or through our website, ucdavisem.com. Then please head over to iTunes and leave us a review. And please pass the word along to your friends and colleagues! ***Please rate us and leave us a review on iTunes! It helps us reach more people.*** Hosts: Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Guest: Dr. Michael Casner, Emergency Physician at Mount Sinai and Holy Cross hospitals in Chicago, IL, and part-time Emergency Medicine Faculty at the University of Missouri, Kansas City, MO.  Resources: HIV.gov PrEP information and resources Ready, Set, PrEP - medication at no cost for those who qualify Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2021 Update—A Clinical Practice Guideline  Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428-2438. doi:10.1016/S0140-6736(19)30418-0 Support Dr. Casner's team in the AIDS/LifeCycle! *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services. Dr Mike Casner

Welcome to another special SIAL bonus episodes of The Food Professor podcast!Sylvain and I were thrilled to be the official podcast of the SIAL food innovation trade show held in Montreal in April. We had the opportunity to meet and get to know many food innovators and entrepreneurs, creators and makers from many facets of the food industry.   These are their stories.In this episode:  Meet Gurth M. Pretty, SIAL Cheese Ambassador, Lakeview Cheese Galore Thanks for joining us on this special bonus episode of The Food Professor.  Stay tuned for plenty of great interviews from our podcast studio on the trade show floor in Montreal at SIAL, and stay tuned for our regular full length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.  About Gurth:I am a bilingual, passionate and knowledgeable cheese and sales professional, specializing in both Canadian and international cheese. My experiences include retail merchandising, sales analyses and review, category management, distribution, marketing, brand strategy, corporate training, co-ordinating special events, media spokesman, sales strategies, participating as a judge at international cheese competitions, recipe development, food costing, catering, vendor negotiation and problem solving.Gurth's Bookhttps://amzn.to/3NpDLPOGurth's Cheese Storehttps://lakeviewcheesegalore.ca/  About UsDr. Sylvain CharleboisDr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability.He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star.Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa.Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers perinatal psychiatry with Dr. Tuong Vi Nguyen, Assistant Professor, Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University and Scientist and Scientist, RI-MUHC, Brain Repair and Integrative Neuroscience (BRaIN) Program, Centre for Outcomes Research and Evaluation.    The learning objectives for this episode are as follows:   By the end of this episode, you should be able to… Define the field of perinatal psychiatry Describe the key issues that should be addressed in pre-conception psychiatric counseling Discuss the management approach for prescribing medications during pregnancy Recognize the prevalence of mood disorders during the perinatal period Recall the diagnostic criteria for postpartum depression Consider the risk factors and explanatory models for postpartum depression Discuss the use of screening tools for postpartum depression Outline the treatment for postpartum depression Describe the clinical presentation of postpartum psychosis and recognize the urgency of this condition List important risk factors for postpartum psychosis Discuss the management for postpartum psychosis   Guest: Dr. Tuong Vi Nguyen   Hosts: Nima Nahiddi (PGY4), Audrey Le (PGY1), and Arielle Geist (PGY2)    Produced by: Nima Nahiddi (PGY4), Audrey Le (PGY1), Rebecca Marsh (PGY2) and Arielle Geist (PGY2)    Audio editing by: Audrey Le   Show notes by: Arielle Geist    Interview content: Introduction - 00:00 Learning objectives - 00:43 Defining the field of perinatal psychiatry - 01:55 Key issues to address in preconception counseling - 02:50 Management approach for prescribing medications during pregnancy - 07:00 Prevalence of mood disorders during the perinatal period - 12:11 Diagnostic criteria for postpartum depression - 14:05 Differentiating postpartum psychosis from postpartum depression - 16:52 Risk factors and explanatory models for postpartum depression - 18:58 Screening tools for postpartum depression - 20:15 Treatment for postpartum depression - 22:13 Pharmacotherapy - 22:20 Psychotherapy - 27:34 Clinical presentation of postpartum psychosis - 29:07 Risk factors for postpartum psychosis - 30:43 Postpartum psychosis prognosis and impacts on attachment- 32:57 Management of postpartum psychosis -35:30 Closing comments - 38:00   Resources: Bérard, A., Zhao, J. P., & Sheehy, O. (2017). Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ open, 7(1), e013372. https://doi.org/10.1136/bmjopen-2016-013372 Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016). Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. Jama Pediatrics, 170(2), 117-24. doi: 10.1001/jamapediatrics.2015.3356. Brown, A. S., Gyllenberg, D., Malm, H., McKeague, I. W., Hinkka-Yli-Salomäki, S., Artama, M., Gissler, M., Cheslack-Postava, K., Weissman, M. M., Gingrich, J. A., & Sourander, A. (2016). Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. JAMA psychiatry, 73(11), 1163–1170. https://doi.org/10.1001/jamapsychiatry.2016.2594 Cohen, J. , Hernández-Díaz, S. , Bateman, B. , Park, Y. , Desai, R. , Gray, K. , Patorno, E. , Mogun, H. & Huybrechts, K. (2017). Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstetrics & Gynecology, 130(6), 1192-1201. doi: 10.1097/AOG.0000000000002362. Huybrechts, K. F., Hernández-Díaz, S., Patorno, E., Desai, R. J., Mogun, H., Dejene, S. Z., Cohen, J. M., Panchaud, A., Cohen, L., & Bateman, B. T. (2016). Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA psychiatry, 73(9), 938–946. https://doi.org/10.1001/jamapsychiatry.2016.1520 Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., & Hernández-Díaz, S. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. The New England Journal of Medicine, 370(25), 2397–2407. https://doi.org/10.1056/NEJMoa1312828 Imaz, M. L., Oriolo, G., Torra, M., Soy, D., García-Esteve, L., & Martin-Santos, R. (2018). Clozapine Use During Pregnancy and Lactation: A Case-Series Report. Frontiers in Pharmacology, 9, 264. https://doi.org/10.3389/fphar.2018.00264 Nörby, U., Forsberg, L., Wide, K., Sjörs, G., Winbladh, B., & Källén, K. (2016). Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Pediatrics, 138(5), e20160181. https://doi.org/10.1542/peds.2016-0181 Nörby, U., Winbladh, B., & Källén, K. (2017). Perinatal Outcomes After Treatment With ADHD Medication During Pregnancy. Pediatrics, 140(6), e20170747. https://doi.org/10.1542/peds.2017-0747 Reis, M., & Källén, B. (2013). Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A registered study. BMJ Open, 3, e002166. doi:10.1136/bmjopen-2012-002166 Sundram S. (2006). Cannabis and neurodevelopment: implications for psychiatric disorders. Human psychopharmacology, 21(4), 245–254. https://doi.org/10.1002/hup.762   References: Boland, R., Verduin, M., & Ruiz, P. (2021). Psychopharmacology. In Kaplan & Sadock's synopsis of psychiatry (Twelfth edition.). Philadelphia: Wolters Kluwer. Jones, I., Chandra, P.S., Dazzan, P., & Howard, L.K. (2014). Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet, 384(9956), 1789-1799. doi: 10.1016/S0140-6736(14)61278-2. Nieldson, D., Videbech, P., Hedegaard, M., Dalby, J., & Secher, N.J. (2005). Postpartum depression: identification of women at risk. An International Journal of Obstetrics and Gynaecology, 107(10), 1210-1217. https://doi-org.myaccess.library.utoronto.ca/10.1111/j.1471-0528.2000.tb11609.x Schiller, C.E., Meltzer-Brody, S., & Rubinow, D.R. (2015). The role of reproductive hormones in postpartum depression. CNS Spectrums, 20(1), 48-59. doi: 10.1017/S1092852914000480 Viguera, A. (2021). Mild to moderate postpartum unipolar major depression: Treatment. UpToDate. Accessed 2021-01-18. Wisner, K.L., Sit, D.K.Y., & McShea, M.C. (2013). Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry, 70(5), 490-498. doi:10.1001/jamapsychiatry.2013.87   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

Vi besöker ett härjat Europa, läser The Lancet och Jonas tar farväl av R…

Can we have conscious experiences after clinical death? In this episode we have the bizarre phenomena of Near Death Experiences to examine. The intense experience reported by about %25 of patients whose hearts are restarted after a short time of clinical death, has fascinated researchers for many years going right back to Plato. However, advances in cardiology techniques in the last 50 years have permitted doctors to save many more people, and thus to study the phenomenon in a controlled manner: so, exactly how many people have the experiences, exactly how dead they were at the time and so to start assessing the controversial part of this discussion, whether these experiences can be explained in simply neurobiological terms or if there is evidence that consciousness can ‘survive' clinical death, if that is in fact the best way to talk about it. So who better to help us understand this than cardiologist, scientist and author Dr. Pim Van Lommel from The Netherlands. During his 35 year career as a Cardiologist, Dr. Van Lommel saw the need for a detailed study on this to nail down the physiological variables like medication, length of time without oxygen and to connect those to the psychological data, about the content of the experiences and how long they remained influential in the patients lives. The prospective study he spearheaded was published in the respected Lancet medical journal in 2001, and his book about the research ‘Consciousness beyond life, the science of the near death experience' was published in 2007. He also recently won second prize in the Bigelow Foundation for consciousness studies essay prize, which discusses the study and its implications. Full references, shownotes and links here Please donate a cup of coffee if you're enjoying the show What we discuss in this episode: 03:19 Common experiences during an NDE 05:30 NDEs are possible even when the brain is fully functional e.g. Fear of death emergency 06:44 Carl Jung's NDE was the first description of viewing planet earth from above 07:45 Transformation of world view via NDE + STEs (Spiritually transformative experiences) 08:14 Scientific curiosity about NDEs in clinically dead brains 11:00 1988-1998 Pim's medical and psychological study of NDEs 17:15 Examining neurobiological explanations 27:45 Implications: consciousness must be non-local and the brain an interface 38:30 NDEers report heightened intuitive skill, empathy, precognition and telepathy 46:00 Organisations researching post-materialist science 51:50 Is the information perceived in an NDE different to normal perceptive information? 54:00 Non-local information exchange 59:30 Heightened sense of interconnection with nature and other beings - oneness 01:01:00 Life review: Experiencing from a different consciousness' point of view References: Pim's book ‘Consciousness beyond life: the science of near death experiences'. Pim's medical and psychological study Pim's Bigelow essay prize text 2022 Bigalow Insitute for Consciousness Studies IONS The Journal of Consciousness Studies

One in four adults is physically inactive according to a global health study published in the Lancet a few years ago. That's an enormous number. It doesn't take much research or imagination to figure out that this leads directly to poorer health outcomes – and just a lower quality of life in general. Our bodies need to move for our physical and mental wellbeing. Dave Stapleton, our guest today, is working to solve this problem. Dave played semi-pro rugby in Ireland and then moved to London to work in finance. Because of his years on the field, he prefers outdoor fitness classes. He was taking part in these various bootcamps and high intensity training sessions around London when he realized two things. The first was that outdoor training was more accessible to the people who needed it most. People who feared the judgment or complexity of a gym seemed to see outdoor classes as an entry point to fitness. The second was that the outdoor fitness market was incredibly fractured and disorganized. So Dave did what great entrepreneurs do. He dove deep into market research, found like-minded collaborators, and began to build. The platform he created, BUA FIT, just celebrated facilitating its one millionth engagement, so we wanted to get Dave on the phone from London and hear more about how their journey has played out since StartUp Health invested in the company last year.     Learn more and connect with the team at BUA FIT. Entrepreneurs: How to get investment from StartUp Health startuphealth.com Investors: How to invest in StartUp Health Moonshots healthmoonshots.com Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Welcome to a special bonus episode celebrating the 29th ANNUAL CANADIAN GRAND PRIX NEW PRODUCT AWARDSSylvain and I are thrilled to be a sponsor of these prestigious awards for the third year in a row and have the chance to hand out the hardware on the stage to the winners in person for the first time!We had the opportunity to meet and get to know many fantastic food innovators and entrepreneurs, creators and makers - from consumer brands to private retail labels.   These are their stories.In this episode, meet Manisha (Mistry) Nagar, Private Brands Product Development Manager - Health & Wellness, Consumables, Baby & Pet, Walmart  Thanks for joining us on this special bonus episode of The Food Professor. Stay tuned for plenty of great interviews of the finalists from the Retail Council of Canada's Canadian Grand Prix New Product Awards. And stay tuned for our regular full-length episodes available on Apple Podcasts, Spotify, Google - wherever you enjoy your podcasts today.   About Manisha:A quick learner with 15+ years of Product Development experience from both manufacturing and retail. Accustomed to multi-tasking in a fast-paced, and ever-changing environment.Strong leadership abilities with the ability to communicate, influence and negotiate at all levels. Excellent relationship builder. Always looking for opportunities to improve personally and professionally. Direct New Product Development & Continuous Improvement Ability to manage priorities, multitask and handle complex situations under pressure. Proven ability to prioritize and use time efficiently and effectively.  Problem Solver Analytical Skills Leadership & coaching abilities About UsDr. Sylvain CharleboisDr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph's Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability.He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”. He has also published over 500 peer-reviewed journal articles in several academic publications. Furthermore, his research has been featured in several newspapers and media groups, including The Lancet, The Economist, the New York Times, the Boston Globe, the Wall Street Journal, Washington Post, BBC, NBC, ABC, Fox News, Foreign Affairs, the Globe & Mail, the National Post and the Toronto Star.Dr. Charlebois sits on a few company boards, and supports many organizations as a special advisor, including some publicly traded companies. Charlebois is also a member of the Scientific Council of the Business Scientific Institute, based in Luxemburg. Dr. Charlebois is a member of the Global Food Traceability Centre's Advisory Board based in Washington DC, and a member of the National Scientific Committee of the Canadian Food Inspection Agency (CFIA) in Ottawa.Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest adventure for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!